Community dysfunction in schizophrenia: Rate-limiting factors

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 3, 2006, Pages 463-470

  Bozikas, Vasilis P ^a   Kosmidis, Mary H ^a   Kafantari, Anna ^a   Gamvrula, Katerina ^a   Vasiliadou, Eleni ^a   Petrikis, Petros ^a   Fokas, Kostas ^a   Karavatos, Athanasios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Community functioning; Extrapyramidal symptoms; Neurocognition; Psychopathology; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CORRELATION ANALYSIS; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GREECE; HUMAN; HUMAN RELATION; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PARKINSONISM; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SOCIAL ADAPTATION; SYMPTOM; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

ADULT; ATTENTION; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR DISORDERS;

EID: 33646053144     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.017     Document Type: Article

References (57)

1. Addington J., and Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr, Bull 25 (1999) 173-182
2. Addington J., and Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res 44 (2000) 47-56
3. Addington J., McCleary L., and Munroe-Blum H. Relationship between cognitive and social dysfunction in schizophrenia. Schizophr Res 34 (1998) 59-66
4. Addington J., Young J., and Addington D. Social outcome in early psychosis. Psychol Med 33 (2003) 1119-1124
5. Aksaray G., Oflu S., Kaptanoglu C., and Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 26 (2002) 1217-1219
6. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th Edition (1994), American Psychiatric Press, Washington DC
7. Angermeyer M.C., and Katschnig H. Psychotropic medication and quality of life: a conceptual framework for assessing their relationships. In: Katschnig H., Freeman H., and Sartorius N. (Eds). Quality of life in mental disorders (1997), Wiley, New York 215-225
8. Awad A.G., and Voruganti L.N.P. Quality of life and new antipsychotics in schizophrenia: are patients better off?. Int J Soc Psychiatry 45 (1999) 268-275
9. Chouinard G., Ross-Chouinard A., Annable L., and Jones B.D. Extrapyramidal rating scale. Can J Neurol Sci 7 (1980) 233
10. 2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry 157 (2000) 1019-1020
11. 2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 160 (2003) 303-309
12. Delis D.C., Kramer J.H., Kaplan E., and Ober B.A. California Verbal Learning Test (CVLT) Manual (1987), Psychological Corporation, New York
13. Dernovsek M.Z., Prevolnik Rupel V., Rebolj M., and Tavcar R. Quality of life ant treatment costs in schizophrenic outpatients, treated with depot neuroleptics. Eur Psychiatry 16 (2001) 474-482
14. Dickerson F., Boronow J.J., Ringel N., and Parente F. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr Res 37 (1999) 13-20
15. Dickerson F., Boronow J.J., Ringel N., and Parente F. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr Res 37 (1999) 13-20
16. Dickinson D., and Coursey R.D. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophr Res 56 (2002) 161-170
17. Fitzgerald P.B., de Castella A.R.A., Filia K., Collins J., Brewer K., Williams C.L., Davey P., and Kulkarni J. A longitudinal study of patient- and observer-rated quality of life in schizophrenia. Psychiatry Res 119 (2003) 55-62
18. Folia V., and Kosmidis M.H. Assessment of memory skills in illiterates: strategy differences or test artifacts?. Clin Neuropsychol 17 (2003) 143-152
19. Gerlach J., and Larsen E.B. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatr Scand 99 Suppl. 395 (1999) 113-117
20. Grant C., Addington J., Addington D., and Konnert C. Social functioning in first- and multiepisode schizophrenia. Can J Psychiatry 46 (2001) 746-749
21. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 153 (1996) 321-330
22. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull 26 (2000) 119-136
23. Green M.F., Kern R.S., Robertson M.J., Sergi M.J., and Kee K.S. Relevance of neurocognitive deficits for functional outcome in schizophrenia. In: Sharma T., and Harvey P. (Eds). Cognition in Schizophrenia: Impairments, Importance and Treatment Strategies (2000), Oxford University Press, New York 178-192
24. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test: revised and expanded (1993), Psychological Assessment Resources, Odessa, FL
25. Heinrichs D.W., Hanlon T.E., and Carpenter Jr. W.T. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10 (1984) 388-398
26. Heslegrave R.J., Awad A.G., and Voruganti L.N.P. The influence of neurocognitive deficits and symptoms in quality of life in schizophrenia. J Psychiatr Neurosci 22 (1997) 235-243
27. Hooper H.E. The Hooper Visual Organization Test (1957), Western Psychological Services, Los Angeles, California
28. Jones-Gotman M., and Milner B. Design fluency: the invention of nonsense drawings after focal cortical lesions. Neuropsychologia 15 (1977) 653-674
29. 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 187 (2000) 514-520
30. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
31. Kosmidis M.H., Vlahou C.H., Panagiotaki P., and Kiosseoglou G. The verbal fluency task in the Greek population: normative data and clustering and switching strategies. J Int Neuropsychol Soc 10 (2004) 164-172
32. Larsen E.B., and Gerlach J. Subjective experience of treatment, side effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatr Scand 93 (1996) 381-388
33. Lehoux C., Everett J., Laplante L., Émond C., Trépanier J., Brassard A., et al. Fine motor dexterity is correlated to social functioning in schizophrenia. Schizophr Res 62 (2003) 269-273
34. Lykouras E., Botsis A., and Oulis P. The Positive and Negative Syndrome Scale (PANSS) (1994), Tsiveriotis Ed, Athens (in Greek)
35. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou G.N., et al. Five-factor model of schizophrenic psychopathology: how valid is it?. Eur Arch Psychiatry Clin Neurosci 250 (2000) 93-100
36. Malla A.K., Norman R.M.G., McLean T.S., and McIntosh E. Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version). Acta Psychiatr Scand 103 (2001) 355-361
37. Mueser K.T. Cognitive functioning, social adjustment and long-term outcome in schizophrenia. In: Sharma T., and Harvey P. (Eds). Cognition in schizophrenia: impairments, importance and treatment strategies (2000), Oxford University Press, New York 157-177
38. Norman R.M.G., Malla A.K., Cortese L., Cheng S., Diaz K., McIntosh E., et al. Symptoms and cognition as predictors of community functioning: a prospective analysis. Am J Psychiatry 156 (1999) 400-405
39. Opler L.A., Kay S.R., Lindenmayer J., and Fiszbein A. SCI-PANSS (1992), Multi-Health Systems Inc, Toronto
40. Owens Cunningham D.G. A guide to the extrapyramidal side-effects of antipsychotic drugs (1999), Cambridge University Press, Cambridge
41. Penn D.L., Mueser K.T., Spaulding W., Hope D.A., and Reed D. Information processing and social competence in chronic schizophrenia. Schizophr Bull 21 (1995) 269-281
42. Priebe S., Roeder-Wanner U.-U., and Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychol Med 30 (2000) 225-230
43. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8 (1958) 271-276
44. Rempfer M.V., Hamera E.K., Brown C.E., and Cromwell R.L. The relations between cognition and independent living skill of shopping in people with schizophrenia. Psychiatry Res 117 (2003) 103-112
45. Revheim N., and Medalia A. Verbal memory, problem-solving skills and community status in schizophrenia. Schizophr Res 68 (2004) 149-158
46. Ritsner M., Ponizovsky A., Endicott J., Nechamkin Y., Rauchverger B., Silver H., et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 12 (2002) 31-38
47. Ritsner M. Predicting changes in domain-specific quality of life of schizophrenia patients. J Nerv Ment Dis 191 (2003) 287-294
48. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 suppl. 20 (1998) 22-33
49. Simon A.E., Giacomini V., Ferrero F., and Mohr S. Dysexecutive syndrome and social adjustment in schizophrenia. Aust New Zealand J Psychiatry 37 (2003) 340-346
50. Smith T.S., Hull J.W., Huppert J.D., and Silverstein S.M. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schizophr Res 55 (2002) 229-237
51. Stroop J.R. Studies of interference in series verbal reactions. J Exp Psychol 18 (1935) 643-662
52. Taylor E.M. Psychological appraisal of children with cerebellar deficits (1959), Harvard University Press, Cambridge
53. Velligan D.I., Mahurin R.K., Diamond P.L., Hazleton B.C., Eckert S.L., and Miller A.L. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res 25 (1997) 21-31
54. Velligan D.I., Bow-Thomas C.C., Mahurin R.K., Miller A.L., and Halgunseth L.C. Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?. J Nerv Ment Dis 188 (2000) 518-524
55. Vlahou C.H., and Kosmidis M.H. The Greek Trail Making Test: preliminary normative data for clinical and research use. Psychlology 9 (2002) 336-352 (in Greek)
56. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-third edition (1997), San Psychological Corporation, San Antonio, TX
57. Wechsler D. Wechsler Memory Scale-third edition (1997), Psychological Corporation, San Antonio, TX